The effect of thrombosis aspiration combined ticagrelor on myocardial perfusion and prognosis of primary PCI for STEMI

The effect of thrombosis aspiration combined ticagrelor on myocardial perfusion and prognosis of pr

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005315

Enrollment

Unknown

Registered

2014-09-04

Start date

2014-09-11

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST segment elevation myocardial infarction

Interventions

A:asprin+ticagrelor+heparin

B:asprin+ticagrelor+bivalirudin

C:asprin+clopidogrel+heparin

Eligibility

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: STEMI patients undergoing primary PCI.

Exclusion criteria

Exclusion criteria: (1) hypersensitivity to asprin, tigeralor, heparin; (2) who need to undergo emergency coronary artery bypass surgery; (3) who has already received thrombolytic therapy; Save type PCI patients; (4) Killip more than and equal to level III; (5) Severe renal dysfunction, serum creatinine more than and equal to 3mg/dl

Design outcomes

Primary

Measure	Time frame
Electrocardiogram(ECG);Serum troponin T(cTnT);Serum creatine kinase(CK-MB);NT-proBNP;Measure left ventricular ejection fraction through;Measure infarction area through ultrasound angiogr;Bleeding complications of introperation and postop;The incidence of major adverse cardiovascular even;Reinfarction;Target vessel revascularization (TVR);	—

Countries

China

Contacts

Public ContactYuhua Zhao

zhao19661@163.com+86 13549393086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026